Global and China CAR T-Cell Therapy Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the CAR T-Cell Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • CARsgen Therapeutics (China)

    • Mustang Bio (US)

    • Autolus Therapeutics PLC (UK)

    • Pfizer, Inc (US)

    • Juno Therapeutics (US)

    • Cellectis (France)

    • Legend Biotech (US)

    • Novartis AG (Switzerland)

    • Sorrento Therapeutics (US)

    • Kite Pharma (US)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Allogeneic

    • Autologous

    Application:

    • Hospitals

    • Cancer Research Centers

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 CAR T-Cell Therapy Industry Overview

      • 1.1.1 CAR T-Cell Therapy Market Scope and Market Segments

      • 1.1.2 CAR T-Cell Therapy Industry Characteristics

      • 1.1.3 Global and China CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China CAR T-Cell Therapy Production Value and Growth Rate (2017-2028)

    • 1.2 Global CAR T-Cell Therapy Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Allogeneic

      • 1.2.2 Autologous

    • 1.3 Global CAR T-Cell Therapy Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Cancer Research Centers

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global CAR T-Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global CAR T-Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China CAR T-Cell Therapy Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China CAR T-Cell Therapy Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global CAR T-Cell Therapy Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 CAR T-Cell Therapy Industry Porter's Five Forces Model Analysis

      • 2.2.3 CAR T-Cell Therapy Industry PEST Analysis

    • 2.3 CAR T-Cell Therapy Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 CAR T-Cell Therapy Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on CAR T-Cell Therapy Industry

    Chapter 3 Global and China CAR T-Cell Therapy Market, by Manufacturer

    • 3.1 Global and China CAR T-Cell Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China CAR T-Cell Therapy Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China CAR T-Cell Therapy Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China CAR T-Cell Therapy Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China CAR T-Cell Therapy Market Top 3 Players

    Chapter 4 Global and China CAR T-Cell Therapy Market, by Type (2017-2028)

    • 4.1 CAR T-Cell Therapy Market Trend, by Type

    • 4.2 Global CAR T-Cell Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global CAR T-Cell Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global CAR T-Cell Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global CAR T-Cell Therapy Price Trend, by Type (2017-2028)

    • 4.3 China CAR T-Cell Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China CAR T-Cell Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China CAR T-Cell Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China CAR T-Cell Therapy Price Trend, by Type (2017-2028)

    Chapter 5 Global and China CAR T-Cell Therapy Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global CAR T-Cell Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global CAR T-Cell Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global CAR T-Cell Therapy Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China CAR T-Cell Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China CAR T-Cell Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China CAR T-Cell Therapy Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global CAR T-Cell Therapy Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America CAR T-Cell Therapy Market Analysis

    • 7.1 North America CAR T-Cell Therapy Market, by Type

    • 7.2 North America CAR T-Cell Therapy Market, by Application

    • 7.3 North America CAR T-Cell Therapy Market Analysis and Forecast, by Country

      • 7.3.1 United States CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe CAR T-Cell Therapy Market Analysis

    • 8.1 Europe CAR T-Cell Therapy Market, by Type

    • 8.2 Europe CAR T-Cell Therapy Market, by Application

    • 8.3 Europe CAR T-Cell Therapy Market Analysis and Forecast, by Country

      • 8.3.1 Germany CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC CAR T-Cell Therapy Market Analysis

    • 9.1 APAC CAR T-Cell Therapy Market, by Type

    • 9.2 APAC CAR T-Cell Therapy Market, by Application

    • 9.3 APAC CAR T-Cell Therapy Market Analysis and Forecast, by Country

      • 9.3.1 China CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa CAR T-Cell Therapy Market Analysis

    • 10.1 Latin America, Middle East and Africa CAR T-Cell Therapy Market, by Type

    • 10.2 Latin America, Middle East and Africa CAR T-Cell Therapy Market, by Application

    • 10.3 Latin America, Middle East and Africa CAR T-Cell Therapy Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina CAR T-Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China CAR T-Cell Therapy Company Profiles

      • 11.1 CARsgen Therapeutics (China)

        • 11.1.1 CARsgen Therapeutics (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 CARsgen Therapeutics (China) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.1.3 CARsgen Therapeutics (China) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Mustang Bio (US)

        • 11.2.1 Mustang Bio (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Mustang Bio (US) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.2.3 Mustang Bio (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Autolus Therapeutics PLC (UK)

        • 11.3.1 Autolus Therapeutics PLC (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.3.3 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Pfizer, Inc (US)

        • 11.4.1 Pfizer, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Pfizer, Inc (US) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.4.3 Pfizer, Inc (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Juno Therapeutics (US)

        • 11.5.1 Juno Therapeutics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Juno Therapeutics (US) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.5.3 Juno Therapeutics (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Cellectis (France)

        • 11.6.1 Cellectis (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Cellectis (France) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.6.3 Cellectis (France) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Legend Biotech (US)

        • 11.7.1 Legend Biotech (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Legend Biotech (US) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.7.3 Legend Biotech (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Novartis AG (Switzerland)

        • 11.8.1 Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Novartis AG (Switzerland) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.8.3 Novartis AG (Switzerland) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sorrento Therapeutics (US)

        • 11.9.1 Sorrento Therapeutics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sorrento Therapeutics (US) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.9.3 Sorrento Therapeutics (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Kite Pharma (US)

        • 11.10.1 Kite Pharma (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Kite Pharma (US) CAR T-Cell Therapy Product Profiles, Application and Specification

        • 11.10.3 Kite Pharma (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 CAR T-Cell Therapy Industry Investment Prospect and Risk Assessment

    • 12.1 CAR T-Cell Therapy Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 CAR T-Cell Therapy Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Global CAR T-Cell Therapy Production Value and Growth Rate (2017-2028)

    • Figure China CAR T-Cell Therapy Production Value and Growth Rate (2017-2028)

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic (2017-2028)

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Autologous (2017-2028)

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers (2017-2028)

    • Figure Global CAR T-Cell Therapy Market Size and Growth Rate of Others (2017-2028)

    • Figure North America CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa CAR T-Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global CAR T-Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China CAR T-Cell Therapy Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China CAR T-Cell Therapy Sales Value, by Manufacturer (2021&2022)

    • Table Global and China CAR T-Cell Therapy Market Share, by Manufacturer (2021&2022)

    • Figure Global and China CAR T-Cell Therapy Market Share, by Manufacturer in 2021

    • Figure Global and China CAR T-Cell Therapy Market Share, by Manufacturer in 2022

    • Table Global CAR T-Cell Therapy Sales Volume, by Type (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Global CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Value, by Type (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Value Share, by Type (2017-2028)

    • Figure Global CAR T-Cell Therapy Price Trend, by Type (2017-2028)

    • Table China CAR T-Cell Therapy Sales Volume, by Type (2017-2028)

    • Table China CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table China CAR T-Cell Therapy Sales Value, by Type (2017-2028)

    • Table China CAR T-Cell Therapy Sales Value Share, by Type (2017-2028)

    • Figure China CAR T-Cell Therapy Price Trend, by Type (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Volume, by Application (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Global CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Value, by Application (2017-2028)

    • Table Global CAR T-Cell Therapy Sales Value Share, by Application (2017-2028)

    • Figure Global CAR T-Cell Therapy Sales Value Share, by Application (2017-2028)

    • Table China CAR T-Cell Therapy Sales Volume, by Application (2017-2028)

    • Table China CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Table China CAR T-Cell Therapy Sales Value, by Application (2017-2028)

    • Table China CAR T-Cell Therapy Sales Value Share, by Application (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Value Share, by Application (2017-2028)

    • Figure China CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure North America CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Europe CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure APAC CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa CAR T-Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Table North America CAR T-Cell Therapy Sales Volume, by Type (2017-2028)

    • Table North America CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure North America CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table North America CAR T-Cell Therapy Sales Volume, by Application (2017-2028)

    • Table North America CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure North America CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure United States CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure United States CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Canada CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Canada CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Mexico CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table Europe CAR T-Cell Therapy Sales Volume, by Type (2017-2028)

    • Table Europe CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Europe CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table Europe CAR T-Cell Therapy Sales Volume, by Application (2017-2028)

    • Table Europe CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Europe CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Germany CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Germany CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure UK CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure UK CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure France CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure France CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Italy CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Italy CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Spain CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Spain CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Belgium CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Poland CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Poland CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Russia CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Russia CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Turkey CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table APAC CAR T-Cell Therapy Sales Volume, by Type (2017-2028)

    • Table APAC CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure APAC CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table APAC CAR T-Cell Therapy Sales Volume, by Application (2017-2028)

    • Table APAC CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure APAC CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Japan CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Japan CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure India CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure India CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Korea CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa CAR T-Cell Therapy Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa CAR T-Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa CAR T-Cell Therapy Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa CAR T-Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Brazil CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Africa CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Argentina CAR T-Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina CAR T-Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table CARsgen Therapeutics (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CARsgen Therapeutics (China) Product Profiles, Application and Specification

    • Table CARsgen Therapeutics (China) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mustang Bio (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mustang Bio (US) Product Profiles, Application and Specification

    • Table Mustang Bio (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Autolus Therapeutics PLC (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Autolus Therapeutics PLC (UK) Product Profiles, Application and Specification

    • Table Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer, Inc (US) Product Profiles, Application and Specification

    • Table Pfizer, Inc (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Juno Therapeutics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Juno Therapeutics (US) Product Profiles, Application and Specification

    • Table Juno Therapeutics (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cellectis (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cellectis (France) Product Profiles, Application and Specification

    • Table Cellectis (France) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Legend Biotech (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Legend Biotech (US) Product Profiles, Application and Specification

    • Table Legend Biotech (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG (Switzerland) Product Profiles, Application and Specification

    • Table Novartis AG (Switzerland) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sorrento Therapeutics (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sorrento Therapeutics (US) Product Profiles, Application and Specification

    • Table Sorrento Therapeutics (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kite Pharma (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kite Pharma (US) Product Profiles, Application and Specification

    • Table Kite Pharma (US) CAR T-Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.